BRCA2 and breast cancer: We present the results of integrated analysis of miR/mRNA data from the same tumor tissue samples to identify genes that could differentiate between tumor harvested from young patients (aged ≤35 years) with familial BC and those from sporadic BC, not harboring BRCA1/BRCA2 mutations.